Back to top

Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase ...

Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial | OGEN Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Oragenics, Inc. (OGEN)